These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 3815727
21. Nucleoside analogues: 8. Some isomers of B.3839, the original 5-fluorouracil/nitrosourea molecular combination, and their effect on colon, breast and lung tumours in mice. McElhinney RS, McCormick JE, Bibby MC, Double JA, Atassi G, Dumont P, Pratesi G, Radacic M. Anticancer Drug Des; 1989 Jun; 4(1):1-20. PubMed ID: 2757750 [Abstract] [Full Text] [Related]
22. Combination therapy with radiation, mitomycin C, and 5-fluorouracil in EMT6 tumors. Rockwell S. Int J Radiat Oncol Biol Phys; 1994 Jan 01; 28(1):127-33. PubMed ID: 8270433 [Abstract] [Full Text] [Related]
29. Induction of hypoxia in the KHT sarcoma by tumour necrosis factor and flavone acetic acid. Edwards HS, Bremner JC, Stratford IJ. Int J Radiat Biol; 1991 Feb 01; 59(2):419-32. PubMed ID: 1671692 [Abstract] [Full Text] [Related]
30. Toxicity of RSU-1069 for KHT cells treated in vivo or in vitro: evidence for a diffusible toxic product. Hill RP, Gulyas S, Whitmore GF. Int J Radiat Oncol Biol Phys; 1989 Apr 01; 16(4):1111-4. PubMed ID: 2703391 [Abstract] [Full Text] [Related]
31. Is tumour radiosensitization by misonidazole a general phenomenon? Denekamp J, Hirst DG, Stewart FA, Terry NH. Br J Cancer; 1980 Jan 01; 41(1):1-9. PubMed ID: 7362769 [Abstract] [Full Text] [Related]
33. The combined antitumour effect of a new 5-fluorouracil derivative, BOF-A2, and radiation in vivo. Murata R, Shibamoto Y, Miyauchi S, Hirohashi M, Takagi T, Sasai K, Oya N, Hiraoka M. Br J Cancer Suppl; 1996 Jul 01; 27():S114-6. PubMed ID: 8763861 [Abstract] [Full Text] [Related]
34. In vitro and in vivo evaluation of novel antitumor prodrugs of 5-fluoro-2'-deoxyuridine activated by hypoxic irradiation. Shibamoto Y, Tachi Y, Tanabe K, Hatta H, Nishimoto S. Int J Radiat Oncol Biol Phys; 2004 Feb 01; 58(2):397-402. PubMed ID: 14751508 [Abstract] [Full Text] [Related]
35. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models. Schmid FA, Sirotnak FM, Otter GM, DeGraw JI. Cancer Treat Rep; 1987 Feb 01; 71(7-8):727-32. PubMed ID: 3607784 [Abstract] [Full Text] [Related]
36. Preclinical studies of porfiromycin as an adjunct to radiotherapy. Rockwell S, Keyes SR, Sartorelli AC. Radiat Res; 1988 Oct 01; 116(1):100-13. PubMed ID: 3186923 [Abstract] [Full Text] [Related]
37. In vivo evaluation of a novel antitumor prodrug, 1-(2'-oxopropyl)-5-fluorouracil (OFU001), which releases 5-fluorouracil upon hypoxic irradiation. Shibamoto Y, Zhou L, Hatta H, Mori M, Nishimoto SI. Int J Radiat Oncol Biol Phys; 2001 Feb 01; 49(2):407-13. PubMed ID: 11173134 [Abstract] [Full Text] [Related]
38. Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs. Rak J, Kuśnierczyk H, Strzadała L, Kłosiewicz S, Radzikowski C. Arch Immunol Ther Exp (Warsz); 1989 Feb 01; 37(3-4):389-97. PubMed ID: 2639635 [Abstract] [Full Text] [Related]
39. Demonstration of radiosensitization of hypoxic cells in solid tumours by metronidazole. Begg AC, Sheldon PW, Foster JL. Br J Radiol; 1974 Jul 01; 47(559):399-404. PubMed ID: 4851295 [No Abstract] [Full Text] [Related]
40. The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--II. Cyclophosphamide. Twentyman PR, Kallman RF, Brown JM. Int J Radiat Oncol Biol Phys; 1979 Sep 01; 5(9):1425-7. PubMed ID: 536251 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]